Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Nasopharyngeal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05432219
What this trial is testing

A Transoral Retropterygoid Approach to Resect Recurrent Nasopharyngeal Carcinoma

Who this might be right for
Recurrent Nasopharyngeal Carcinoma
Eye & ENT Hospital of Fudan University 20
Not applicableStudy completedNCT00828516
What this trial is testing

Using Traditional Acupuncture in the Management of Cancer Treatment Related Lymphoedema

Who this might be right for
Breast CancerHead and Neck CancerLymphedema
East and North Hertfordshire NHS Trust 56
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06605131
What this trial is testing

GP Combined with Toripalimab Versus GP Induction Chemotherapy for Advanced Childhood Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University 72
Testing effectiveness (Phase 2)Looking for participantsNCT07101744
What this trial is testing

Iparomlimab and Tuvonralimab Combined With Nimotuzumab in Recurrent or Metastatic NPC After First-line Treatment Failure: A Single-arm Phase IIa Clinical Trial

Who this might be right for
Nasopharyngeal Carcinoma (NPC)First-line Treatment Failure Nasopharyngeal Carcinoma
Sun Yat-sen University 41
Not applicableStudy completedNCT00530049
What this trial is testing

Measuring Patient Satisfaction With Facial Appearance: Development and Validation of a New Patient-Reported Outcome Measure

Who this might be right for
Head and Neck CancerPsychosocial Effects of Cancer and Its Treatment
Memorial Sloan Kettering Cancer Center 1,745
Large-scale testing (Phase 3)UnknownNCT02933099
What this trial is testing

Aprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting

Who this might be right for
Chemotherapy-induced Nausea and Vomiting
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 300
Testing effectiveness (Phase 2)UnknownNCT05341193
What this trial is testing

PD-1 Blockade and Bevacizumab Replace Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 32
Not applicableStudy completedNCT00430378
What this trial is testing

Acupuncture for Prevention of Radiation-Induced Xerostomia

Who this might be right for
XerostomiaMouth DrynessNasopharyngeal Cancer
M.D. Anderson Cancer Center 100
Large-scale testing (Phase 3)Looking for participantsNCT07340515
What this trial is testing

Proton vs Photon IMRT in Locally Advanced Nasopharyngeal Carcinoma: A Phase III Trial

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Man Hu 300
Not applicableStudy completedNCT00310115
What this trial is testing

Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy

Who this might be right for
Bladder CancerCervical CancerEsophageal Cancer+8 more
M.D. Anderson Cancer Center 469
Large-scale testing (Phase 3)Looking for participantsNCT07661771
What this trial is testing

Individualized Primary Clinical Target Volume Based on Margin Expansion for Nasopharyngeal Carcinoma

Who this might be right for
Non-metastatic Nasopharyngeal Carcinoma
Sun Yat-sen University 568
Not applicableUnknownNCT06523933
What this trial is testing

Distribution of Bacteria in OME After Radiotherapy For NPC.

Who this might be right for
Otitis Media EffusionNasopharyngeal Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 234
Early research (Phase 1)Looking for participantsNCT06886347
What this trial is testing

Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Metastatic Nasopharyngeal Carcinoma
Chen Xiaozhong 47
Large-scale testing (Phase 3)Looking for participantsNCT03907826
What this trial is testing

PD-1 Antibody Combined With Chemoradiotherapy in Recurrent Nasopharyngeal Carcinoma Patients

Who this might be right for
Recurrent Nasopharyngeal Carcinoma
Sun Yat-sen University 212
Testing effectiveness (Phase 2)WithdrawnNCT05290194
What this trial is testing

Radiotherapy Combined With PD-1 Monoclonal Antibody and Capecitabine in the Treatment of Nasopharyngeal Carcinoma

Who this might be right for
RadiotherapyPD-1 InhibitorCapecitabine+1 more
Fifth Affiliated Hospital, Sun Yat-Sen University
Large-scale testing (Phase 3)Looking for participantsNCT04778956
What this trial is testing

Toripalimab Plus Surgery vs Surgery Alone for Resectable Recurrent Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaPD-1Surgery
Sun Yat-sen University 218
Testing effectiveness (Phase 2)UnknownNCT05898256
What this trial is testing

Cadonilimab in the Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaImmune Checkpoint Inhibitors
Guangxi Medical University 20
Not applicableUnknownNCT05449184
What this trial is testing

A Prospective, Randomized, Controlled Clinical Study of BET Combined With Tympanostomy Tube Insertion in the Treatment of Intractable OME After Radiotherapy for NPC

Who this might be right for
Otitis Media With Effusion After Nasopharyngeal Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 208
Not applicableEnded earlyNCT00891904
What this trial is testing

Radiation Therapy and Cetuximab in Treating Patients With Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Roswell Park Cancer Institute 2
Large-scale testing (Phase 3)Not Yet RecruitingNCT07783321
What this trial is testing

Anti-PD-1 Antibody With or Without BL-B01D1 as Maintenance Therapy Following Anti-PD-1 Antibody Plus Chemotherapy for the First-line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma (PANKU-NPC02)

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Sichuan Baili Pharmaceutical Co., Ltd. 404
Next Page